Showing results (3131-3140 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|March 2, 2012
Lifestyle factors associated with serum N-3 fatty acid levels in breast cancer patientsZora Djuric, Jianwei Ren, Patrick R Brown, et al.Breast (Edinburgh, Scotland)|December 2, 2014
Management of central breast tumours with immediate reconstruction of the nipple-areola complex; a suggested guideLena Carstensen, Janne BigaardBreast (Edinburgh, Scotland)|November 18, 2019
Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trialSteven David, Jennifer Tan, Peter Savas, et al.Breast (Edinburgh, Scotland)|December 17, 2019
Identifying research priorities in the treatment of patients with early breast cancer: from the patient perspectiveKathleen I PritchardBreast (Edinburgh, Scotland)|December 17, 2019
Estimating the magnitude of clinical benefit of local therapy in patients with DCISE Shelley Hwang, Veronika MalekBreast (Edinburgh, Scotland)|December 17, 2019
Targeting immune pathways in breast cancer: review of the prognostic utility of TILs in early stage triple negative breast cancer (TNBC)Elizabeth F Blackley, Sherene LoiBreast (Edinburgh, Scotland)|December 17, 2019
Future options: the potential role of proton irradiationJohn Henry MaduroBreast (Edinburgh, Scotland)|December 17, 2019
Estimating the magnitude of clinical benefit from (neo)adjuvant chemotherapy in patients with ER-positive/HER2-negative breast cancerAmelia McCartney, Matteo Benelli, Angelo Di LeoBreast (Edinburgh, Scotland)|December 17, 2019
Emerging strategies in neoadjuvant treatment of patients with HER2-positive early breast cancerNadia HarbeckBreast (Edinburgh, Scotland)|December 22, 2019
ST2 levels increased and were associated with changes in left ventricular systolic function during a three-year follow-up after adjuvant radiotherapy for breast cancerHanna Aula, Tanja Skyttä, Suvi Tuohinen, et al.Pageof 367